A Chinese digital healthcare company ClouDr Group has announced that it has embedded DeepSeek’s artificial intelligence (AI) technology into its platform to deliver efficiency gains in hospital and pharmacy operations.
The integration of the DeepSeek R1 model into the medical AI platform ClouDr Brain would bolster the platform’s data-mining capabilities to boost clients’ efficiency in handling patients with chronic conditions, Kuang Ming, chairman and CEO, said in a statement to Hong Kong’s bourse on Thursday.
Adoption of DeepSeek by Chinese companies is on the rise after the AI company emerged as China’s hottest tech start-up by stunning experts worldwide with the efficiency of its open-source large language models. The company said its V3 model, released on December 26, was trained in around two months at a cost of US$5.58 million, using significantly fewer computing resources than competing AI products.
“Following this integration and by leveraging [ClouDr’s] over 1 billion electronic health records, the company’s ClouD GPT and ClouD DTx models will achieve functional upgrades regarding the medical knowledge graph and the clinical decision-support system to optimise user experience and improve diagnostic efficiency,” ClouDr said.
Sleep apnea & snoring treatment options
The information on this website is for general educational purpose only. Readers should consult their physician before considering treatment, and should not interpret their condition solely based on the information above. 以上資訊僅提供教育用途。你應該諮詢醫生有關的治療方法，而不應完全依賴網站上的資訊。
